These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8386663)

  • 1. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response.
    Srinivasan M; Domanico SZ; Kaumaya PT; Pierce SK
    Eur J Immunol; 1993 May; 23(5):1011-6. PubMed ID: 8386663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens.
    Fox BS; Chen C; Fraga E; French CA; Singh B; Schwartz RH
    J Immunol; 1987 Sep; 139(5):1578-88. PubMed ID: 2442249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
    Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of class II MHC allelic control of T cell responses.
    Racioppi L; Ronchese F; Schwartz RH; Germain RN
    J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides related to the antigenic determinant block T cell recognition of the native protein as processed by antigen-presenting cells.
    Lakey EK; Margoliash E; Flouret G; Pierce SK
    Eur J Immunol; 1986 Jul; 16(7):721-7. PubMed ID: 2424770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of L3T4 and Ia in the heteroclitic response of T cells to cytochrome c.
    Lakey EK; Margoliash E; Fitch FW; Pierce SK
    J Immunol; 1986 Jun; 136(11):3933-8. PubMed ID: 2422265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant.
    Bhayani H; Carbone FR; Paterson Y
    J Immunol; 1988 Jul; 141(2):377-82. PubMed ID: 2454990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of a minimal antigenic peptide alters its interaction with MHC molecules.
    Fox BS; Carbone FR; Germain RN; Paterson Y; Schwartz RH
    Nature; 1988 Feb; 331(6156):538-40. PubMed ID: 2448649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire.
    Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU
    Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.
    Nikcevich KM; Kopielski D; Finnegan A
    J Immunol; 1994 Aug; 153(3):1015-26. PubMed ID: 7517970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.